With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

We recently compiled a list of the 10 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

A new storage technique can keep protein-based drugs and vaccines stable without keeping them cold. The discovery, led by ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new therapeutics, a system set ...

Eli Lilly partnership aims to identify new treatments for ALS based on antibodies from people with very slow disease ...

Oxford, UK and San Jose, California, 9 January 2024 - Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of ...

Absci recently received a $20 million PIPE investment from AMD that improves its runway and R&D platform with AI. See why I ...

Under the terms of the deal, Alchemab and Lilly will work together on up to five new antibodies, according to a Jan. 9 ...

CEO of ImmunoPrecise Antibodies. "By harnessing AI and rethinking drug discovery from the ground up, we are not just improving the process—we are fundamentally changing what’s possible.